Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
58,646.97 +871.54 (+1.51%) CMC Crypto 200
1,268.99 -1.75 (-0.14%)
Exelixis, Inc. (EXEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 23.46 |
| Open | 21.52 |
| Bid | 21.91 x 1700 |
| Ask | 22.13 x 1700 |
| Day's range | 20.69 - 22.24 |
| 52-week range | 18.52 - 24.34 |
| Volume | |
| Avg. volume | 2,349,955 |
| Market cap | 6.387B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 33.73 |
| EPS (TTM) | 0.65 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.74 |
ZacksExelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Exelixis (EXEL) misses on earnings and sales in the first quarter. Its shares are trading down in response to the results.
- GuruFocus.com
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Exelixis reports robust financial performance and outlines key strategies in oncology asset development and commercial expansion.
© 2024 Yahoo. All rights reserved.